Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
New York, NY 10016Phone+1 212-731-5445Fax+1 718-731-5545
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
- Washington University in St. Louis School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2013 - 2025
- MA State Medical License 2002 - 2015
Publications & Presentations
PubMed
- 5 citationsCombination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.Pamela Munster, Nicholas Iannotti, Daniel C Cho, John M Kirkwood, Liza C Villaruz
Cancer Research Communications. 2023-12-19 - 11 citationsFirst-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1).Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen
Journal for Immunotherapy of Cancer. 2023-03-01 - 31 citationsFirst-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, Daniel C Cho, Sarah P Blagden
Journal for Immunotherapy of Cancer. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: